Single-blind, randomized, controlled phase I/II study to compare the safety and immunogenicity of an inactivated influenza vaccine (whole virion, vero cell derived) with a license egg derived influenza vaccine

Trial Profile

Single-blind, randomized, controlled phase I/II study to compare the safety and immunogenicity of an inactivated influenza vaccine (whole virion, vero cell derived) with a license egg derived influenza vaccine

Completed
Phase of Trial: Phase I/II

Latest Information Update: 14 Oct 2015

At a glance

  • Drugs Influenza A vaccine H5N1-Baxter (Primary) ; Influenza virus vaccine
  • Indications Influenza virus infections
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Baxter BioScience; Baxter Healthcare Corporation
  • Most Recent Events

    • 16 Oct 2007 Status changed from in progress to completed.
    • 18 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top